BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 15215133)

  • 1. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
    Ergin A; Ercis S; Hasçelik G
    J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
    Acikgoz ZC; Gocer S; Tuncer S
    J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
    Koh EH; Kim S; Lee NY
    Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
    Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
    J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D
    Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
    Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
    Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C; Domenech A; Rolo D; Calatayud L; Tubau F; Ayats J; Martín R; Liñares J
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and antibiotic resistance of group A streptococci isolated from healthy schoolchildren in Korea.
    Kim S; Lee NY
    J Antimicrob Chemother; 2004 Aug; 54(2):447-50. PubMed ID: 15269193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide resistance in beta-hemolytic streptococci: changes after the implementation of the separation of prescribing and dispensing of medications policy in Korea.
    Kim HY; Uh Y
    Yonsei Med J; 2004 Aug; 45(4):591-7. PubMed ID: 15344198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC; Göçer S; Almayanlar E
    Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
    Megged O; Assous M; Weinberg G; Schlesinger Y
    Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
    Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
    J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
    [No Abstract]   [Full Text] [Related]  

  • 19. Presence of plasmid pA15 correlates with prevalence of constitutive MLS(B) resistance in group A streptococcal isolates at a university hospital in southern Taiwan.
    Liu YF; Wang CH; Janapatla RP; Fu HM; Wu HM; Wu JJ
    J Antimicrob Chemother; 2007 Jun; 59(6):1167-70. PubMed ID: 17460027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].
    Artiles Campelo F; Horcajada Herrera I; Alamo Antúnez I; Cãnas Pedrosa A; Lafarga Capuz B
    Rev Esp Quimioter; 2007 Sep; 20(3):317-22. PubMed ID: 18080028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.